– Novant Health names Jvion as the inaugural partner for their Institute of Innovation and Artificial Intelligence.
– Together, Jvion will identify Novant patients with a preventable risk of CHF readmission and recommend patient-specific interventions to prevent readmission.
Today, Novant announced the inaugural partner for their Institute of Innovation and Artificial Intelligence would be Jvion, a leader in prescriptive analytics for preventable harm. Together, they aim to use Jvion’s AI-enabled analytics to drive down readmission rates for congestive heart failure patients, which can be as high as 35% in the first year and double with each subsequent hospitalization.
Initial Programs to Reduce CHF Readmissions by $1M
Jvion will identify Novant patients with a preventable risk of CHF readmission and recommend patient-specific interventions to prevent readmission. Novant Health will leverage the Jvion Machine, which helps prevent patient harm and associated costs by enabling clinical staff to focus attention, resources, and individualized interventions on patients whose outcomes can be improved. Unlike traditional AI and predictive analytic solutions that merely identify high-risk patients and cause alarm fatigue, Jvion pinpoints the impactable patients on a changeable risk trajectory and provides the patient-specific recommendations that will drive to a better outcome.
Based on 4,500 data points from 16 million patients and a unique use of Eigen-based models, Novant will be able to quickly apply Jvion’s technology to heart failure patients and extend it to additional conditions down the line. Unlike other predictive AI tools, Jvion incorporates socioeconomic and environmental data points along with EHR data into their analysis, providing the most comprehensive view of patient risk factors on the market. The Novant Health solution will be deployed as a cloud instance on Microsoft Azure.
Why It Matters
“AI-enabled prescriptive analytics represent a new, innovative approach to using clinical and socioeconomic data to pinpoint the most impactful interventions for individuals suffering from diseases, such as CHF, that can be managed or prevented,” said Shantanu Nigam, Jvion CEO. “We are excited to partner with Novant Health, a leader committed to leveraging new technologies to save lives, improve quality of care and impact key quality measures.”
“With AI-based technologies like Jvion, our care teams can move faster and with more precision to address some of the community’s most serious health concerns – in this case, reducing readmissions for patients with congestive heart failure,” said Angela Yochem, Novant Health executive vice president and chief digital and technology officer. “This partnership with Jvion expands our AI portfolio and builds on our commitment to use leading-edge technology to connect with and care for our patients.”